InvestorsHub Logo
icon url

sukus

02/04/20 12:02 AM

#263047 RE: iwasadiver #263044

Superb! Agreed.
icon url

erik007tc

02/04/20 1:17 AM

#263049 RE: iwasadiver #263044

Excellent!
icon url

Umibe5690

02/04/20 2:31 AM

#263051 RE: iwasadiver #263044

Sounds very encouraging.

You also have made a very broad statement stated as a fact that the....."scientific community, particularly the glio set are salivating...." Just curious and not questioning the veracity but how do you know this? Have you taken a poll? I presume by scientific community you mean more than the 69 authors of the JTM article, the NWNO SAB and the medical centre where you work and which is a site for the trial.
icon url

Kam8

02/04/20 2:32 AM

#263052 RE: iwasadiver #263044

Excellent post. Thanks
icon url

eagle8

02/04/20 4:44 AM

#263053 RE: iwasadiver #263044


Thanks iwasadiver.
Great post.

GLTU
icon url

Truthfan

02/04/20 5:31 AM

#263054 RE: iwasadiver #263044

IWD....

Many of us will start our day with your most encouraging and appropriate post on this World Cancer Day - February 4th.
icon url

iclight

02/04/20 12:30 PM

#263131 RE: iwasadiver #263044

The scientific community, particularly the Glio set, are salivating at what appears to be happening with survival.



And yet Susan Bayh who was on the friggin BOD in 2016 (probably shortly after the futility rec during the efficacy IA) is getting treated at Duke with their non-DCVax immunotherapy.

icon url

sentiment_stocks

02/04/20 1:17 PM

#263141 RE: iwasadiver #263044

it’s simply kind of like a guarantee against some cowboy FDA bureaucrat thinking he/she’s going to make an attempt at being virtuous in some biased way against NWBO’s trial



That's my thinking as well.

No one needs another Dr. Sher and Dr. Hussain on an AdCom advising against an approval like they did to Dendreon in 2007.

The guidelines make it clear the direction the FDA is heading, and the direction advisements on approval should steer towards.